Product logins

Find logins to all Clarivate products below.


Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2019

The global MIVCF treatment device market will be driven mainly by the growing aging and obese population across the globe. Furthermore, new product launches and increasing adoption of advanced premium-priced technologies will help overcome obstacles such as unfavorable reimbursement environments. Therefore, the market will see moderate growth through 2027. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for MIVCF treatment devices in the global region across a 10-year period.

Related Medtech Insights Reports

Report
Minimally Invasive Vertebral Compression Fracture Treatments – Market Insights – Global
Despite the negative impact of COVID-19, the global MIVCF treatment market is expected to show modest growth through 2033, driven by moderate growth in the Asia Pacific region and sustained…
Report
Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2023
Despite the short-term negative impact of the COVID-19 pandemic, the global market for MIVCF treatments will show particularly strong growth through 2031, reflecting the moderate growth in the…
Report
Minimally Invasive Vertebral Compression Fracture Treatments | Market Insights | Global | 2021
The global MIVCF treatment device market will be driven mainly by increasingly positive clinical opinion of MIVCF procedures. Furthermore, the growing aging and obese populations across the…
Report
Deep Venous Disease Treatment Devices | Market Insights | Global | 2020
The global market for deep venous disease treatment devices consists of a combination of the mature deep venous disease treatment thrombectomy and thrombolysis and PTA balloon catheter segments,…
Report
Peripheral Vascular Devices | Market Insights | Japan | 2020
The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and …